MX2016000464A - Incremento del potencial osteogenico de los injertos oseos. - Google Patents
Incremento del potencial osteogenico de los injertos oseos.Info
- Publication number
- MX2016000464A MX2016000464A MX2016000464A MX2016000464A MX2016000464A MX 2016000464 A MX2016000464 A MX 2016000464A MX 2016000464 A MX2016000464 A MX 2016000464A MX 2016000464 A MX2016000464 A MX 2016000464A MX 2016000464 A MX2016000464 A MX 2016000464A
- Authority
- MX
- Mexico
- Prior art keywords
- enhancement
- bone grafts
- osteogenic potential
- invention concerns
- vivo treatment
- Prior art date
Links
- 210000000988 bone and bone Anatomy 0.000 title abstract 3
- 230000002188 osteogenic effect Effects 0.000 title abstract 2
- 102000013814 Wnt Human genes 0.000 abstract 2
- 108050003627 Wnt Proteins 0.000 abstract 2
- 101000954805 Homo sapiens Protein Wnt-3a Proteins 0.000 abstract 1
- 102000056781 human WNT3A Human genes 0.000 abstract 1
- 230000004083 survival effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/365—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Botany (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Marine Sciences & Fisheries (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361957946P | 2013-07-16 | 2013-07-16 | |
| PCT/US2014/046852 WO2015009829A2 (en) | 2013-07-16 | 2014-07-16 | Enhancement of osteogenic potential of bone grafts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016000464A true MX2016000464A (es) | 2016-04-07 |
Family
ID=52346837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016000464A MX2016000464A (es) | 2013-07-16 | 2014-07-16 | Incremento del potencial osteogenico de los injertos oseos. |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US9301980B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3021943B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6557659B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102307174B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN105431202B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2014290042B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2916898A1 (cg-RX-API-DMAC7.html) |
| GB (2) | GB2578557B (cg-RX-API-DMAC7.html) |
| IL (1) | IL243288B (cg-RX-API-DMAC7.html) |
| MX (1) | MX2016000464A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015009829A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201600095B (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017023542A1 (en) | 2015-07-31 | 2017-02-09 | DePuy Synthes Products, Inc. | Method of preparing an osteogenic bone graft |
| US11491262B2 (en) * | 2018-04-19 | 2022-11-08 | Paulo Jose PASQUALI | Method of bone regeneration |
| EP3787645A4 (en) * | 2018-05-02 | 2022-06-01 | Ortheus, Inc. | SYSTEMS AND METHODS FOR LOCAL MODULATION OF WNT SIGNALING |
| CN111700881B (zh) * | 2020-07-02 | 2021-05-18 | 四川大学 | Wnt蛋白\ZIF-8纳米复合体、其制备方法及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5550289A (en) | 1985-01-07 | 1996-08-27 | Syntex (U.S.A.) Inc. | N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor |
| US5705655A (en) | 1992-12-17 | 1998-01-06 | Megabios Corporation | Amphiphilic nitrogen containing imidazolinium derivative compounds and uses |
| KR960705798A (ko) | 1993-11-24 | 1996-11-08 | 벤자민 에프 맥그로우 | 피페라진의 양쪽친화성 유도체(amphiphilic derivatives of piperazine) |
| KR960705771A (ko) | 1993-11-24 | 1996-11-08 | 벤자민 에프 맥그로우 | 구아니딘의 양쪽친화성 유도체(amphiphilic derivatives of guanidine) |
| CA2194221C (en) | 1994-06-22 | 2001-01-02 | Megabios Corporation | Cationic amphiphiles |
| DE19521412A1 (de) | 1995-06-14 | 1996-12-19 | Boehringer Mannheim Gmbh | Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung |
| JP2004507236A (ja) * | 2000-08-18 | 2004-03-11 | プロスケリア | 骨粗鬆症の診断および治療に有用な調節遺伝子および系 |
| US6723131B2 (en) * | 2001-02-28 | 2004-04-20 | The Cleveland Clinic Foundation | Composite bone marrow graft material with method and kit |
| EP1660663A4 (en) * | 2003-08-12 | 2007-07-11 | Brigham & Womens Hospital | METHOD AND COMPOSITIONS FOR TISSUE REPAIR |
| US8343922B2 (en) * | 2004-05-19 | 2013-01-01 | Enzo Biochem, Inc. | Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells |
| CN1846793B (zh) * | 2005-04-14 | 2011-08-03 | 南方医院 | 一种组织工程骨及其构建与应用 |
| WO2008109119A2 (en) * | 2007-03-05 | 2008-09-12 | The Board Of Trustees Of The Leland Stanford Junior University | Wnt compositions and methods of use thereof |
| JP5458238B2 (ja) * | 2007-11-30 | 2014-04-02 | 一郎 小野 | 臓器再生用デバイス |
| US9526737B2 (en) | 2007-12-03 | 2016-12-27 | The Regents Of The University Of California | Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and Wnt signaling |
| SI2331109T1 (sl) * | 2008-08-22 | 2013-10-30 | Anthrogenesis Corporation | Postopki in sestavki za zdravljenje okvar kosti s populacijami placentarnih celic |
| WO2010111278A1 (en) * | 2009-03-23 | 2010-09-30 | The Texas A&M University System | Compositions of mesenchymal stem cells to regenerate bone |
| WO2012034070A1 (en) * | 2010-09-09 | 2012-03-15 | The Board Of Trustees Of The Leland Stanford Junior University | Use of liposomal wnt compositions to enhance osseointegration |
| WO2012135176A2 (en) * | 2011-03-28 | 2012-10-04 | The Board Of Trustees Of The Leland Stanford Junior University | The use of wnt agents to prevent hypoxic injury |
-
2014
- 2014-07-16 EP EP14827030.9A patent/EP3021943B1/en active Active
- 2014-07-16 GB GB2001056.7A patent/GB2578557B/en not_active Expired - Fee Related
- 2014-07-16 CN CN201480040557.6A patent/CN105431202B/zh not_active Expired - Fee Related
- 2014-07-16 JP JP2016527073A patent/JP6557659B2/ja not_active Expired - Fee Related
- 2014-07-16 KR KR1020167002073A patent/KR102307174B1/ko not_active Expired - Fee Related
- 2014-07-16 WO PCT/US2014/046852 patent/WO2015009829A2/en not_active Ceased
- 2014-07-16 CN CN202010166831.1A patent/CN111643733B/zh not_active Expired - Fee Related
- 2014-07-16 US US14/333,220 patent/US9301980B2/en active Active
- 2014-07-16 AU AU2014290042A patent/AU2014290042B2/en not_active Ceased
- 2014-07-16 GB GB1600149.7A patent/GB2530224B/en not_active Expired - Fee Related
- 2014-07-16 MX MX2016000464A patent/MX2016000464A/es unknown
- 2014-07-16 CA CA2916898A patent/CA2916898A1/en active Pending
-
2015
- 2015-12-27 IL IL243288A patent/IL243288B/en active IP Right Grant
-
2016
- 2016-01-06 ZA ZA2016/00095A patent/ZA201600095B/en unknown
- 2016-03-07 US US15/063,317 patent/US9925304B2/en not_active Expired - Fee Related
-
2018
- 2018-01-11 US US15/868,395 patent/US10568989B2/en active Active
-
2019
- 2019-07-12 JP JP2019129823A patent/JP6897996B2/ja not_active Expired - Fee Related
- 2019-08-30 AU AU2019222935A patent/AU2019222935B2/en not_active Ceased
-
2020
- 2020-01-15 US US16/743,837 patent/US11771803B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016010293A (es) | Micro-organoides, y metodos de fabricacion y usos los mismos. | |
| MX2019013670A (es) | Formulaciones de anticuerpos y proteinas. | |
| SG10201810723VA (en) | Improved t cell compositions | |
| EP4640273A3 (en) | Inducible caspases and methods for use | |
| EA201101522A1 (ru) | Способы лечения болезней с использованием эпиметаболического переключателя (коэнзим q10) | |
| WO2016070166A3 (en) | Messenger una molecules and uses thereof | |
| MX2021013665A (es) | Proteinas de union a calicreina en plasma y usos de las mismas para tratar el angioedema hereditario. | |
| UY33826A (es) | Proteínas de unión con dominios trivariables y sus usos | |
| WO2017015622A8 (en) | Gdf11 binding proteins and uses thereof | |
| HK1220980A1 (zh) | 用於治疗庞贝氏症的方法和组合物 | |
| AR090973A1 (es) | Anticuerpos utiles para el diagnostico del cancer | |
| PH12014501844B1 (en) | Peptidomimetic macrocycles | |
| CY1117214T1 (el) | Συνθεση για ελεγχομενη διεγερση των ωοθηκων | |
| EP3687546A4 (en) | COMPOSITIONS AND METHODS FOR TREATMENT OF HEART DISEASE VIA RETARGETED T-CELL IMMUNOTHERAPIES | |
| WO2017055613A3 (en) | Combination therapy using inhibitors of human growth and differentiation factor 15 (gdf-15) and immune checkpoint blockers | |
| MX2018002546A (es) | Composiciones que comprenden un compuesto de urolitina. | |
| WO2014134084A3 (en) | Phf20 and jmjd3 compositions and methods of use in cancer immunotherapy | |
| PH12019502036A1 (en) | Peptides and methods for the treatment of diabetes | |
| PH12017501070A1 (en) | Peptides and their use in the treatment of skin | |
| EA201890439A1 (ru) | ИММУНООНКОЛОГИЧЕСКАЯ МЕЗОДЕРМАЛЬНАЯ КЛЕТКА-ПРЕДШЕСТВЕННИК (ioMP-КЛЕТКА) | |
| EP3057535A4 (en) | Bone grafts including osteogenic stem cells, and methods relating to the same | |
| AU2018262805A1 (en) | Peptides for treatment of diabetes | |
| GB2530224A (en) | Enhancement of osteogenic potential of bone grafts | |
| EP3152297A4 (en) | Use of anti-aging glycopeptides to enhance pancreatic cell health, survival and improve transplant outcome | |
| EA201992875A1 (ru) | T-клетки со сниженным поверхностным фукозилированием и способы их получения и применения |